参考文献/References:
[1]陆荣强,徐爱军.国外公立医院治理结构特点及对我国的启示[J].卫生经济研究,2009(11):24-26.
[2]Rowland D, Allyson, Pollock M,et al.The british labour government's reform of the national health service[J].Journal of Public Health Policy,2001,22(4):403-414.
[3]Medical Healthcare Products Regulatory Agency. Medical devices: the regulations and how we enforce them[EB/OL].(2019)[2020-12-01].https://www.gov.uk/government/publications/report-a-non-compliant-medical-device-enforcement-process/how-mhra-ensures-the-safety-and-quality-of-medical-devices.
[4]郭传骥,郭启勇.国内外医保支付方式和医疗服务体系的现状分析及启示[J].现代医院管理,2018,16(1):66-72.
[5]NICE. Guide to the processes of technology appraisal[EB/OL].(2018) [2020-12-01].https://www.nice.org.uk/process/pmg19/resources/guide-to-the-processes-of-technology-appraisal-pdf-72286663351237.
[6]吕兰婷,余浏洁.英国NICE医用耗材准入流程及启示[J].中国医疗保险,2019(10):77-80.
[7]NICE. Medtech innovation briefings[EB/OL].[2020-12-01].https://www.nice.org.uk/about/what-we-do/our-programmes/nice-advice/medtech-innovation-briefings.
[8]IDR Medical. The reimbursement environment for medical device in the UK[EB/OL]. (2018)[2020-12-01].https://info.idrmedical.com/blog/medical-device-pricing-strategy-reimbursement.
[9]NHS England. National supply system for high-cost tariff-excluded devices[EB/OL].[2020-12-01].https://www.england.nhs.uk/commissioning/spec-services/key-docs/medical-devices.[10]Department of Health and Social Care. High cost device[EB/OL]. (2012)[2020-12-01].https://www.gov.uk/government/publications/high-cost-devices.
[11]NHS England. High cost drugs and devices-2019[EB/OL]. (2019)[2020-12-01].https://www.engage.england.nhs.uk/survey/0fad6f51/.
[12]NHS England. National supply system for high-cost tariff-excluded devices[EB/OL]. [2020-12-01]. https://www.england.nhs.uk/commissioning/spec-services/key-docs/medical-devices.
[13]Nicholas Timmins. Tackling variations in clinical care assessing the Getting It Right First Time (GIRFT) programme[EB/OL].(2017)[2020-12-01]. https://www.kingsfund.org.uk/publications/tackling-variations-clinical-care.
相似文献/References:
[1]邱英鹏赵翔肖月赵羽西.高值医用耗材定义与治理内涵研究[J].中国卫生质量管理,2021,28(05):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01
]
QIU Yingpeng,ZHAO Xiang,XIAO Yue.The Definition and Governance Connotation of High Value Medical Consumables[J].Chinese Health Quality Management,2021,28(05):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01
]
[2]邱英鹏李理然赵羽西肖月.人工晶体卫生技术评估方法学分析及启示[J].中国卫生质量管理,2021,28(05):004.[doi:10.13912/j.cnki.chqm.2021.28.5.02
]
QIU Yingpeng,LI Liran,ZHAO Yuxi.Methodological Analysis and Implications of Health Technology Assessment of Intraocular Lens[J].Chinese Health Quality Management,2021,28(05):004.[doi:10.13912/j.cnki.chqm.2021.28.5.02
]
[3]邱英鹏赵羽西赵翔肖月.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(05):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04
]
QIU Yingpeng,ZHAO Yuxi,ZHAO Xiang.Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications[J].Chinese Health Quality Management,2021,28(05):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04
]
[4]孙辉金春林刘昕王昊德符雨嫣王海银.高值医用耗材价值评估框架研究[J].中国卫生质量管理,2022,29(06):009.[doi:10.13912/j.cnki.chqm.2022.29.6.03
]
SUN Hui,JIN Chunlin,LIU Xin.Value Evaluation Framework of High-Value Medical Consumables[J].Chinese Health Quality Management,2022,29(05):009.[doi:10.13912/j.cnki.chqm.2022.29.6.03
]
[5]王悦刘莉孙驰蒋筠宋辉郑晨陈勇张云峰.提高高值医用耗材管理信息追溯覆盖率[J].中国卫生质量管理,2023,30(04):082.[doi:10.13912/j.cnki.chqm.2023.30.4.20
]
WANG Yue,LIU Li,SUN Chi.Improving the Management Information Traceability Coverage Rate of High Value Medical Consumables[J].Chinese Health Quality Management,2023,30(05):082.[doi:10.13912/j.cnki.chqm.2023.30.4.20
]
[6]林海蓓刘昕罗莉郑蕴欣罗力金春林王海银.基于多准则决策分析的公立医院高值医用耗材准入指标及权重研究[J].中国卫生质量管理,2023,30(11):064.[doi:10.13912/j.cnki.chqm.2023.30.11.14
]
LIN Haibei,LIU Xin,LUO Li.Access Indicators and Weights of High-Value Medical Consumables in Public Hospitals Based on Multi-Criteria Decision Analysis[J].Chinese Health Quality Management,2023,30(05):064.[doi:10.13912/j.cnki.chqm.2023.30.11.14
]